Navigation Links
Vital Access Reports Live VWING Clinical Cases and SAVE Study Clinical Data Presentation at CiDA Conference
Date:10/30/2013

SALT LAKE CITY, Oct. 30, 2013 /PRNewswire/ -- Vital Access Corporation today announced that on Friday, October 25th, Dr. John Ross, MD, FACS performed live VWING Vascular Needle Guide implantation cases and Dr. William Jennings, MD, FACS presented clinical data from the pivotal U.S. SAVE study at the 2013 Controversies in Dialysis Access (CiDA) Meeting in San Francisco.

As part of the CiDA conference agenda, Dr. John Ross performed three VWING implantation cases at his surgical facilities in Orangeburg, South Carolina, two of which were broadcast live to a large audience of physicians. These three cases represent common challenges faced by patients and clinicians in achieving vascular access. The first case involved a cephalic vein arteriovenous fistula (AVF) exhibiting a short usable length, where the VWING was implanted to provide an additional cannulation site for the patient and to extend the usable length of the fistula. The second case involved a non-transposed brachiobasilic AVF where the VWING was implanted to allow cannulation of the fistula in its native position without having to transpose or elevate the vessel. The third case involved a deep radiocephalic vein AVF where the VWING was implanted to permit cannulation of the vessel in its current position and avoid a more-invasive surgical elevation procedure. In all three cases, the VWING was implanted to facilitate easier access to the fistula to allow for safe and effective dialysis treatment. Following the cases, Dr. Ross stated, "For the difficult to cannulate fistula, the standard of care may have been changed by the VWING."

Dr. William Jennings presented results from the recently completed U.S. SAVE study, an IDE pivotal trial of the VWING™ Vascular Needle Guide that supported the recent U.S. market clearance of the device. Dr. Jennings, who was a principal investigator for the SAVE study at the University of Oklahoma in Tulsa, also discussed VWING surgical techniques and cannulation practice. Dr. Jennings described his experience with the VWING, stating, "I expect the device will be an important option for vascular access surgeons. Non-usable fistulas were easily converted to a reliable vascular access quickly, using the VWING implanted in a relatively minor procedure.  Both patients and staff were very pleased with the outcomes."

Doug Smith, President and CEO of Vital Access, summarized the activities of the meeting, stating, "In addition to the live cases and scheduled SAVE study report, we were pleased to see the VWING discussed on several other occasions throughout the conference. The response during and after CiDA has been very encouraging."

About Vital Access™:

Vital Access Corporation is a privately held company located in Salt Lake City that designs and manufactures surgical and interventional technologies to improve vascular access for patients and caregivers. The VWING™ Vascular Needle Guide is commercially available in the U.S., Europe, Canada, and New Zealand. For more information, call 801-433-9390 or visit www.vital-access.com.

Contact: Doug Smith, 801-433-9390


'/>"/>
SOURCE Vital Access Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
2. The Largest Private Funder Of Melanoma Research Receives Vital Support From Activist Jeffrey Epstein
3. inVentiv Medical Management Forms Partnership with Vital Decisions
4. New Survey Affirms Compounding Pharmacies Vital Role in Public Health
5. Finesse Solutions Turns to HiveMind Marketing to Revitalize Website
6. Frost & Sullivan: Appropriate Channel Partners Vital in the Highly Fragmented Medical Devices Distribution Market in VITSK
7. Medical Devices 2013: A Frost & Sullivan Executive MindXchange- Sustaining the Vitality of the Industry and Your Company
8. Best Practices Involving Product Innovation and Creation of Value Vital for Customer Retention, Finds Frost & Sullivan
9. Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies
10. Frost & Sullivan: Government Support Vital to Encourage Venture Capital Investments in the North American Healthcare Industry
11. Competitive Pricing Vital in the Asia-Pacific Digital and Computed Radiography Market, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Avillion LLP, a co-developer and financier of late-stage pharmaceutical product candidates, ... Chief Medical Officer. Dr Weinberg will be based in ... ... 17 years as a pharmaceutical and biotech executive with experience ranging ... of his career, he has interfaced with the US Food & ...
(Date:1/19/2017)... -- Report Details What can be expected ... to grow at the fastest rates? This visiongain report ... opportunities and prospects. Our 190-page report provides 124 ... in the industry and the future market prospects. Our ... all the major categories of the ophthalmic devices market. ...
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast to ... ) today announced it will release results for the fourth quarter ... ... host a conference call at 4:30 PM ET on Wednesday, February ... full year 2016 financial results and other corporate activities. To participate ...
Breaking Medicine Technology:
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate Institute’s Alumni Association ... of events for its annual meeting “Coming Home 2017,” an activity-packed weekend of ... 2017” will be held on Friday January 27 through Sunday, January 29, 2017 ...
(Date:1/21/2017)... ... , ... In the United States, 20 million women and 10 million men ... feel shame for having struggled with an eating disorder as well as common co-occurring ... in Life After an Eating Disorder” -- to be featured at this year’s iaedp ...
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it ... to couches to dressers and bicycles. Roadie — the national on-the-way delivery network — ... center through February 28th. , “January is an exciting time when resolutions are ...
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... supplement development, announced it attended the January ECRM trade show to continue the marketing ... technologically advanced vitamin C supplement, known for providing 400 percent better absorption than traditional ...
(Date:1/20/2017)... , ... January 20, 2017 , ... ... products to enhance people’s everyday lives, recently attended the January ECRM Trade Show ... ATP Science is known for its large range of supplements that keep the ...
Breaking Medicine News(10 mins):